| MonoMethyl auristatin E |
一甲基澳瑞他汀 E |
474645-27-7 |
| pilaralisib |
2-氨基-N-[3-[N-[3-[(2-氯-5-甲氧基苯基)氨基]喹喔啉-2-基]氨基磺酰基]苯基]-2-甲基丙酰胺 |
934526-89-3 |
| SP2509 |
无中文名称 |
1423715-09-6 |
| Enasidenib |
恩西地平 |
1446502-11-9 |
| ABBV-075 |
米维布塞 |
1445993-26-9 |
| Ozanimod |
奥扎莫德 |
1306760-87-1 |
| VcMMAE |
单甲基奥瑞他汀E |
646502-53-6 |
| 4-[(5,6,7,8-TETRAHYDRO-5,5,8,8-TETRAMETHYL-2-NAPHTHALENYL)CARBOXAMIDO]BENZOIC ACID |
4-[(5,6,7,8-四氢-5,5,8,8-四甲基-2-萘基)甲酰氨基]苯甲酸 |
102121-60-8 |
| Rifamycin Sodium |
利福霉素钠 |
14897-39-3 |
| PAC1 |
PAC1 |
315183-21-2 |
| Oprozomib |
ONX0912 |
935888-69-0 |
| LY2090314 |
LY 2090314 |
603288-22-8 |
| KU57788(NU7441) |
8-(4-二苯并噻吩基)-2-(4-吗啉基)-4H-1-苯并吡喃-4-酮 |
503468-95-9 |
| Ethylenebis(oxyethylenenitrilo)tetraacetic acid |
乙二醇双(2-氨基乙基醚)四乙酸 |
67-42-5 |
| 3-(3,4-Difluorobenzoyl)-1,2,3,6-tetrahydro-1,1-dimethylazepino[4,5-b]indole-5-carboxylic acid 1-methylethyl ester |
3-(3,4-二氟苯甲酰基)-1,2,3,6-四氢-1,1-二甲基氮杂卓[4,5-B]吲哚-5-甲酸 1-甲基乙基酯 |
629664-81-9 |
| CHK2 INHIBITOR II |
2-(4-(4-CHLOROPHENOXY)PHENYL)-1H-BENZO[D]IMIDAZOLE-5-CARBOXAMIDE |
516480-79-8 |
| SCH772984 |
(R)-1-(2--2-氧(4-(4-(嘧啶-2-基)苯基)对二氮己环-1-基)乙基)-N-(3-(吡啶-4-基)-1H--5INDAZOL-基)吡咯烷-3-甲酰胺 |
942183-80-4 |
| Ibrutinib |
依鲁替尼 |
936563-96-1 |
| 5-Chloro-N2-[(1S)-1-(5-fluoro-2-pyrimidinyl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)-2,4-pyrimidinediamine |
5-氯-N2-[(1S)-1-(5-氟-2-嘧啶基)乙基]-N4-(5-甲基-1H-吡唑-3-基)-2,4-嘧啶二胺 |
935666-88-9 |
| IDO-IN-1 |
4-氨基-N-(3-溴-4-氟苯基)-N'-羟基-1,2,5-恶二唑-3-甲脒 |
914638-30-5 |
QQ
微信
